Jim Broderick, M.D.

Partner, Morgenthaler Ventures
Dr. Broderick is a Partner on the Morgenthaler Life Sciences Team and invests in companies developing innovative biotech and medical device therapeutic products. Dr. Broderick is the founding CEO and Board member at Setpoint Medical , a Boston-based company developing medical devices to treat inflammatory diseases. Dr. Broderick is a co-founder and board member of Promedior Pharmaceuticals, a Malvern Pennsylvania-based company developing drugs to prevent and treat fibrotic diseases such as end stage renal disease, liver cirrhosis, and radiation therapy-induced fibrosis. Dr. Broderick is the Chairman of the Board for Trellis Bioscience, a South San Francisco, California-based biotech company focused on developing and producing totally human therapeutic monoclonal antibodies Dr. Broderick opened Morgenthaler’s Boston Office in 2005 after spending several years in Silicon Valley. Trained as a physician and an engineer, Dr. Broderick is a graduate of MIT and University of Massachusetts. Dr. Broderick was a member of the Kauffman Fellows Program, a two–year educational fellowship sponsored by the Kauffman Center for Entrepreneurial Leadership designed to train future venture capitalists and leaders of high growth companies. Dr. Broderick had previously worked as a consultant at Mercer Management Consulting, and as a resident at Duke University Medical Center.